Difference between revisions of "Pharm Tech Agenda 2014.06.12"
Jump to navigation
Jump to search
| (12 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | =09:30 - | + | =09:30 - 09:45 Welcome= |
| − | + | *Participants | |
*Review and Approve Agenda | *Review and Approve Agenda | ||
*Approval of minutes of TCon May 22, 2014 | *Approval of minutes of TCon May 22, 2014 | ||
| + | :* [http://wiki.ihe.net/index.php?title=Pharm_Tech_Minutes_2014.05.22 http://wiki.ihe.net/index.php?title=Pharm_Tech_Minutes_2014.05.22] | ||
| − | = | + | =09:45 - 11:15 CP processing= |
* The following (simple) CPs '''''will be asked for approval WITHOUT reviewing''''' them in detail (unless concrete comments are given): | * The following (simple) CPs '''''will be asked for approval WITHOUT reviewing''''' them in detail (unless concrete comments are given): | ||
| − | |||
:* CP-PHARM-068, Add more samples to Active Ingredient structure | :* CP-PHARM-068, Add more samples to Active Ingredient structure | ||
:* CP-PHARM-069, Add terms to glossary | :* CP-PHARM-069, Add terms to glossary | ||
| Line 16: | Line 16: | ||
:* CP-PHARM-076, Renaming of chapters to align to naming policy | :* CP-PHARM-076, Renaming of chapters to align to naming policy | ||
:* CP-PHARM-077, Adding Narrative Text element to supply element | :* CP-PHARM-077, Adding Narrative Text element to supply element | ||
| + | :* CP-PHARM-079, Added missing “Specialty” to Data Element Specification | ||
| + | :* CP-PHARM-080, Correction to CP-PHARM-046 and CP-PHARM-047 | ||
| + | :* CP-PHARM-081, Improve descriptions of Documents, Sections and Entries | ||
| − | + | '''''They are either very short or pretty trivial -> Please prepare to these CPs by reviewing them in advance to determine if you have questions or comments. Otherwise approval is assumed.''''' | |
* The following (complex) CPs '''''will be reviewed in detail and asked for approval''''': | * The following (complex) CPs '''''will be reviewed in detail and asked for approval''''': | ||
| − | + | :* CP-PHARM-063, Introduce a “Dosing Information” Content Module and restructure the PRE, PADV, DIS documents to reference this Content Module for Dosing Information | |
| − | :* CP-PHARM-063, | ||
:* CP-PHARM-065, Enhance Medication packaging structure (asSuperContent, expirationDate) | :* CP-PHARM-065, Enhance Medication packaging structure (asSuperContent, expirationDate) | ||
:* CP-PHARM-066, Add new status: "SUSPEND" | :* CP-PHARM-066, Add new status: "SUSPEND" | ||
| Line 28: | Line 30: | ||
:* CP-PHARM-074, Introduce effectiveTime to specify the time the “code” (e.g. CANCEL) of the PADV shall become effective | :* CP-PHARM-074, Introduce effectiveTime to specify the time the “code” (e.g. CANCEL) of the PADV shall become effective | ||
:* CP-PHARM-078, Adding Status Code element to supply element to indicate whether this Dispensation Item is “partially” or “fully” fulfilling an underlying Prescription Item | :* CP-PHARM-078, Adding Status Code element to supply element to indicate whether this Dispensation Item is “partially” or “fully” fulfilling an underlying Prescription Item | ||
| + | :* CP-PHARM-082, Add Pharmaceutical Adviser / Dispenser at section level (to be consistent with PRE) | ||
| + | :* CP-PHARM-083, Add additional constraints to underlying PCC Medications template | ||
| + | :* CP-PHARM-084, Add additional constraints to underlying PCC Supply template | ||
| + | :* CP-PHARM-085, Lower constraint for referenced PADV from SHALL to SHALL IF KNOWN | ||
| + | '''''These CPs are either introducing an important change or require thorough review. We will discuss them in detail, but it’s important that you have studied the content in advance to increase our efficiency at the F2F.''''' | ||
| Line 46: | Line 53: | ||
=14:30 - 15:15 Extending Pharmacy Whitepaper Admission/Discharge (Michael)= | =14:30 - 15:15 Extending Pharmacy Whitepaper Admission/Discharge (Michael)= | ||
*Discussion | *Discussion | ||
| − | |||
=15:15 - 15:45 Updates to HMW (Jose)= | =15:15 - 15:45 Updates to HMW (Jose)= | ||
| Line 61: | Line 67: | ||
* Public Comment processing | * Public Comment processing | ||
* Approval as new profile | * Approval as new profile | ||
| + | |||
| + | [[Pharmacy Technical Committee]] | ||
| + | |||
| + | [[Category: Agenda]] | ||
Latest revision as of 13:47, 15 June 2014
09:30 - 09:45 Welcome
- Participants
- Review and Approve Agenda
- Approval of minutes of TCon May 22, 2014
09:45 - 11:15 CP processing
- The following (simple) CPs will be asked for approval WITHOUT reviewing them in detail (unless concrete comments are given):
- CP-PHARM-068, Add more samples to Active Ingredient structure
- CP-PHARM-069, Add terms to glossary
- CP-PHARM-070, Align Purpose and Scope to Glossary
- CP-PHARM-071, Improve definition of "Patient instructions" and "Fulfillment instructions"
- CP-PHARM-072, Pharmacy Common Editorial Changes
- CP-PHARM-075, Clarify meaning of statusCode
- CP-PHARM-076, Renaming of chapters to align to naming policy
- CP-PHARM-077, Adding Narrative Text element to supply element
- CP-PHARM-079, Added missing “Specialty” to Data Element Specification
- CP-PHARM-080, Correction to CP-PHARM-046 and CP-PHARM-047
- CP-PHARM-081, Improve descriptions of Documents, Sections and Entries
They are either very short or pretty trivial -> Please prepare to these CPs by reviewing them in advance to determine if you have questions or comments. Otherwise approval is assumed.
- The following (complex) CPs will be reviewed in detail and asked for approval:
- CP-PHARM-063, Introduce a “Dosing Information” Content Module and restructure the PRE, PADV, DIS documents to reference this Content Module for Dosing Information
- CP-PHARM-065, Enhance Medication packaging structure (asSuperContent, expirationDate)
- CP-PHARM-066, Add new status: "SUSPEND"
- CP-PHARM-067, Clarify meaning of "Amounts of consumable to be dispensed" and "Quantity supplied" in the context of medicinal products containing multiple active ingredients
- CP-PHARM-073, Make PADV capable to record also other kind of concerns than just ones caused by other Prescription-/ or Dispense items (e.g., by Allergy, etc.)
- CP-PHARM-074, Introduce effectiveTime to specify the time the “code” (e.g. CANCEL) of the PADV shall become effective
- CP-PHARM-078, Adding Status Code element to supply element to indicate whether this Dispensation Item is “partially” or “fully” fulfilling an underlying Prescription Item
- CP-PHARM-082, Add Pharmaceutical Adviser / Dispenser at section level (to be consistent with PRE)
- CP-PHARM-083, Add additional constraints to underlying PCC Medications template
- CP-PHARM-084, Add additional constraints to underlying PCC Supply template
- CP-PHARM-085, Lower constraint for referenced PADV from SHALL to SHALL IF KNOWN
These CPs are either introducing an important change or require thorough review. We will discuss them in detail, but it’s important that you have studied the content in advance to increase our efficiency at the F2F.
- All CPs are available for download at: ftp://ftp.ihe.net/Pharmacy/TF_Maintenance-2014/CPs/Incoming
- An overview about all Pharmacy CPs we’ve had so far is located at: ftp://ftp.ihe.net/Pharmacy/Technical_Framework/CP%20Overview/CP%20Overview.xlsx
11:15 - 11:45 Break
11:45 - 13:30 Medication Management (Michael/Stephen)
- Work on document "Medication Management Related Concepts and Definitions"
13:30 - 14:30 Lunch
14:30 - 15:15 Extending Pharmacy Whitepaper Admission/Discharge (Michael)
- Discussion
15:15 - 15:45 Updates to HMW (Jose)
- Discussion
15:45 - 16:15 Medication Catalog (e.g. Formulary) (Jose/Simon)
- Discussion
16:15 - 16:45 Update on Healthcare Product Supply Interoperability (Jose)
16:45 - 17:15 Break
17:15 - 18:00 Pharmacy Medication List (Jürgen)
- Public Comment processing
- Approval as new profile